Table 2:

Treatment rates by policy period

Treatment	Dec 2017 - Apr 2018 (Pre-Policy) N = 1,606	Dec 2018 - Apr 2019 (Post-policy) N = 1,567	absolute difference (%)
None	468 (29)	550 (35)	6% [95% CI, 2.7% to 9.3%]
Exception	57 (3.5)	241 (15)	12% [95% CI, 9.8% to 14%]
Low-dose Inotropes	375 (23)	88 (5.6)	−18% [95% CI, −20% to −15%]
LVAD	428 (27)	383 (24)	−2.2% [95% CI, −5.3% to 0.89%]
High-dose Inotropes	142 (8.8)	91 (5.8)	−3% [95% CI, −4.9% to −1.2%]
IABP	73 (4.5)	128 (8.2)	3.7% [95% CI, 1.9% to 5.4%]
Other MCS	41 (2.6)	45 (2.9)	0.3% [95% CI, −0.88% to 1.5%]
ECMO	22 (1.4)	41 (2.6)	1.2% [95% CI, 0.21% to 2.3%]